Loading…
Conference App Sponsor: Pfizer Injectables
View analytic
Tuesday, July 31 • 4:00pm - 5:00pm
Antimicrobial De-escalation: Clinical Approach to Antimicrobial Optimization

Sign up or log in to save this to your schedule and see who's attending!

Download Presentation

  Abstract:   The benefits of early adequate antimicrobial therapy are well-established in medical literature. Typically when antimicrobial therapy is initiated, broad spectrum antimicrobials are used. The concept of antimicrobial de-escalation is switching to a less broad spectrum agent once the infectious syndrome is accurately diagnosed while taking into account culture data and other clinical symptoms present in the patient. This presentation will focus on identifying candidates for streamlining and the clinical and cost benefits of narrowing antimicrobial therapy.

Learning Objectives:
     1.    Describe the benefits of antibiotic streamlining.
     2.    Identify potential candidates for de-escalation of therapy.
     3.    Describe the consequences of over-using antimicrobial agents.

1 contact hour: P                                                                                  0262-9999-12-010-L01-P (K)


Speaker
JB

Jeff Brock, PharmD

Jeff Brock, PharmD, has been employed at Mercy Medical Center since 1995 where he directs the antimicrobial stewardship program. He received a B.A. of science in pharmacy from Drake University, a PharmD from University of Kansas and an MBA from the University of Iowa.


Tuesday July 31, 2012 4:00pm - 5:00pm
Room 114

Attendees (0)